PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 3,655.00
+15.00 (0.41%)
Apr 3, 2026, 3:30 PM KST
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 80.09 billion as of April 2, 2026. Its market cap has increased by 4.02% in one year.
Market Cap
80.09B
Enterprise Value
85.44B
Revenue
171.66B
Ranking
n/a
PE Ratio
680.17
Stock Price
3,655.00
Market Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 80.09B, an increase of 635.32%. That is a compound annual growth rate of 6.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 80.09B | -12.03% |
| Dec 30, 2025 | 91.05B | 22.74% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 73.37T |
| Celltrion | 43.02T |
| ALTEOGEN | 18.84T |
| Sam Chun Dang Pharm. | 14.16T |
| Oncocross | 87.81B |
| Humasis | 82.26B |
| Ray Co., Ltd. | 82.07B |
| BIT Computer | 81.81B |